China Healthcare Weekly (Mar.25)- Viable Business Model for Pharma, CXO for CGT, China Sleep Economy
The strategy of Eli Lilly could be a good reference for domestic pharmaceutical companies.CXO for CGT is a better investment option.The sleep...
300 Views
Pre-IPO Beijing Mabworks Biotech - MIL62 Alone Cannot Save the Situation
This article mainly analyzed Mabworks Biotech in terms of the important clinical-stage drug candidates (MIL62, MIL93, MBS301, MIL97, MIL95, MIL86,...
288 Views
Transcenta (创胜) IPO Trading: Share Concentration
We look at the updates of Transcenta IPO since our last note. We think the debut performance is likely poor given the lack of interest and the fair...
244 Views
ECM Weekly (19th September 2021) - PHC, StarHealth, TDCX, Biel Crystal, DRCBank, Transcenta, Broncus
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
396 Views
Transcenta (创胜) IPO: Fairly Valued Despite Downsizing
We provide an update of the deal terms and the valuation for the Transcenta's book building. We think the deal is fairly valued despite its...
301 Views